RIM
UTHR icon

Rakuten Investment Management’s United Therapeutics UTHR Stock Holding History

Rakuten Investment Management’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1,820
Closed -$915K – 598
2025
Q4 		$915K Sell
1,820
-2,529
-58% -$1.18M ﹤0.01% 518
2025
Q3 		$484K Buy
+4,349
New +$1.46M ﹤0.01% 568
2025
Q1 		$359K Buy
+1,170
New +$401K ﹤0.01% 608
2024
Q3 		$276K Buy
771
+156
+25% +$52.7K ﹤0.01% 474
2024
Q2 		$195K Buy
615
+208
+51% +$55.1K ﹤0.01% 472
2024
Q1 		$93.5K Buy
407
+373
+1,097% +$84.2K ﹤0.01% 490
2023
Q4 		$7.45K Buy
+34
New +$7.84K ﹤0.01% 500

Other funds holding UTHR

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return

Rakuten Investment Management's UTHR Position: Q1 2026 in Review

Rakuten Investment Management sold out of United Therapeutics (UTHR) in Q1 2026, closing a stake of 1,820 shares — an estimated $915K sold.

Rakuten Investment Management first reported a position in UTHR in Q4 2023 and held it in 7 quarters. The position peaked at $915K in Q4 2025. 851 funds tracked by Wall St. Rank hold UTHR as of Q1 2026.

  • Rakuten Investment Management reported no remaining United Therapeutics position as of Q1 2026 after selling out during the quarter.
  • Rakuten Investment Management sold 1,820 United Therapeutics shares in Q1 2026, an estimated $915K.
  • Rakuten Investment Management first reported a position in United Therapeutics in Q4 2023 and held it in 7 quarters.
  • Rakuten Investment Management's United Therapeutics position peaked at $915K in Q4 2025.
  • 851 funds tracked by Wall St. Rank held United Therapeutics as of Q1 2026.

Based on Rakuten Investment Management's 13F filing for Q1 2026, filed 12 May 2026.